Solriamfetol for the treatment of excessive daytime sleepiness in participants with obstructive sleep apnea with different levels of adherence to primary OSA therapy: Subgroup analysis of a randomized clinical trial
- DOI
- 10.1016/j.sleep.2025.106706
- Published
- 2025-10
- Container
- Sleep Medicine
- Publisher
- Elsevier BV
- Open access
- unknown
Credibility signals
uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- supportingDOI registered: A matching record was returned by Crossref.
- supportingDOI resolves: A matching record was returned by Crossref.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- supportingMetadata completeness: All 6 scored descriptive metadata groups are present.
Cite this work
BibTeX
@article{allodium:10.1016/j.sleep.2025.106706,
title = {Solriamfetol for the treatment of excessive daytime sleepiness in participants with obstructive sleep apnea with different levels of adherence to primary OSA therapy: Subgroup analysis of a randomized clinical trial},
author = {Jiucheng Shen and Kaida Guo and Jing Wang and Zhijun Wang and Shiyuan Gao and Qiaojun Wang and Fei Han and Weijia Zhang and Xiang Li and Hui Ye and Rui Chen},
year = {2025},
journal = {Sleep Medicine},
doi = {10.1016/j.sleep.2025.106706},
url = {https://doi.org/10.1016/j.sleep.2025.106706}
}RIS
TY - JOUR TI - Solriamfetol for the treatment of excessive daytime sleepiness in participants with obstructive sleep apnea with different levels of adherence to primary OSA therapy: Subgroup analysis of a randomized clinical trial AU - Jiucheng Shen AU - Kaida Guo AU - Jing Wang AU - Zhijun Wang AU - Shiyuan Gao AU - Qiaojun Wang AU - Fei Han AU - Weijia Zhang AU - Xiang Li AU - Hui Ye AU - Rui Chen PY - 2025 JO - Sleep Medicine DO - 10.1016/j.sleep.2025.106706 UR - https://doi.org/10.1016/j.sleep.2025.106706 ER -
APA
Shen, J., Guo, K., Wang, J., Wang, Z., Gao, S., Wang, Q., Han, F., Zhang, W., Li, X., Ye, H., & Chen, R. (2025). Solriamfetol for the treatment of excessive daytime sleepiness in participants with obstructive sleep apnea with different levels of adherence to primary OSA therapy: Subgroup analysis of a randomized clinical trial. Sleep Medicine. https://doi.org/10.1016/j.sleep.2025.106706
Source records
- crossref · retrieved 2026-09-25T05:50:13.674Z